Form D · Biotechnology

Helix Holdings I, LLC

San Mateo, CA · CIK 0001647032

Offering snapshot reported Jul 8, 2021 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 8, 2021Initial$50,000,001No comparisonNot reportedSEC filing
Apr 28, 2017Amendment$185,000,000$55,000,000vs Dec 23, 201613SEC filing
Dec 23, 2016Amendment$130,000,000$21,666,666vs Jul 29, 201512SEC filing
Jul 29, 2015Initial$108,333,334No comparison3SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-405641

Source: Form D, filed Jul 8, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeff Bird Director
Jeffrey Bird Director
Mark M. Colodny Director
Jay Flatley Director
Justin Kao Executive
Noah Knauf Director
Amr Kronfol Director
James Lu Director, Executive
Barry Schuler Director
Marc Stapley Director
Robin Thurston Director, Executive
Debbie Tuck Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
101 S Ellsworth Avenue, Suite 350
San Mateo, CA, 94401